Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion type Assertion NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_head.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion description "[We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_provenance.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion evidence source_evidence_literature NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_provenance.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion SIO_000772 22057234 NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_provenance.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion wasDerivedFrom befree-20140225 NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_provenance.
- NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_assertion wasGeneratedBy ECO_0000203 NP458800.RASOerclQIbCifj2GMMMJF-eFJe8sDFJUGvtp1ZWsmj_A130_provenance.